Levonorgestrel And Ethinyl Estradiol Kit
Product Images NDC 60505-4898

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Levonorgestrel And Ethinyl Estradiol (NDC 60505-4898). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Apotex Corp., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Blister (Blister)

Blister (Blister)
This information is related to a medication called Levonorgestrel and Ethinyl Estradiol tablets. The medication comes in a package containing 28 tablets arranged in a blister card format. It should be stored at room temperature (20°C to 25°C) and kept out of reach of children. The manufacturer is Apotex Corp.*
FDA Label Image

Carton (Carton)

Carton (Carton)
FDA Label Image

Figure-2 (Figure 2)

Figure-2 (Figure 2)
This text provides information on different studies assessing the risk of breast cancer associated with the use of combined oral contraceptives. Various studies such as the NICHD Women's Contraceptive Study, French E3N cohort Study, Shangai Women's Health Study, Nurses' Health Study, Oxford Family Planning Association Study, and Danish Sex Hormone Register Study are mentioned. The data includes both "Ever use" and "Current use" of contraceptives, along with effect estimates represented as odds ratios (OR) or relative risks (RR). The text seems to present a summary of findings, but further details on methodology and specific results may be necessary for a comprehensive evaluation.*
FDA Label Image

Levonorgestrel-ethinyl-estradiol-fig1 (Levonorgestrel Ethinyl Estradiol Fig1)

Levonorgestrel-ethinyl-estradiol-fig1 (Levonorgestrel Ethinyl Estradiol Fig1)
This is a table showing the concentration levels of Levonorgestrel and Ethinyl Estradiol in ng/mL and pg/mL at different time points (Day 1, Day 6, Day 21) for hours W 2, W 0, and W 8.*
FDA Label Image

Levonorgestrel-ethinyl-estradiol-fig2 (Levonorgestrel Ethinyl Estradiol Fig2)

Levonorgestrel-ethinyl-estradiol-fig2 (Levonorgestrel Ethinyl Estradiol Fig2)
This information seems to be about circulatory disease mortality rates per 100,000 woman years based on different factors like age, smoking status, and oral contraceptive use. It provides data on mortality rates for different groups such as ever-users (non-smokers and smokers) and controls (non-smokers and smokers) in the specified age category. The text also includes numerical values for these mortality rates.*
FDA Label Image

Levonorgestrel-ethinyl-estradiol-str (Levonorgestrel Ethinyl Estradiol Str)

Levonorgestrel-ethinyl-estradiol-str (Levonorgestrel Ethinyl Estradiol Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.